Risankizumab
Also known as Skyrizi (us)
Risankizumab-rzaa injection is used to treat plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) psoriatic arthritis (condition that causes joint pain and swelling and scales on the skin) Crohn's disease (a condition in which the body attacks the lining of th…
Based on 30 MLs per month. US $22,759.41 vs India $214.23 per ML.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $4,058,131
- Estimated travel cost
- − $2,300
- Net savings after travel
- $4,055,831
Even after travel, you could come out ahead by about $4,055,831.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Risankizumab is filled about 102.4K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.